SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Monsanto Co.
MTC 3.230+5.6%Dec 12 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: twt who wrote (1186)2/16/1999 3:07:00 PM
From: Anthony Wong   of 2539
 
From Merrill Lynch's Weekly Prescription Trends (Feb. 16):

Investment Highlights

Cox-2 Inhibitors: Pfizer/Monsanto's Celebrex is off to a great start
with 91,466 (+98.3%) new prescriptions written for the week of
February 5. This product will be officially launched next week.

01/25 01/22 01/29 02/05
__________________________________________________________

Celebrex 39 9,490 46,125 91,466
Week/week % change 24,233% 386.0% 98.3%
___________________________________________________________
Source: IMS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News